Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor - Results of a 1 year multicentre feasibility study
A. Ohlsson et al., Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor - Results of a 1 year multicentre feasibility study, EUR HEART J, 22(11), 2001, pp. 942-954
Background Implantable sensors that monitor haemodynamics over time may be
useful in patients with heart failure. This multicentre study assessed the
feasibility of a system that has one sensor measuring absolute pressure and
another measuring mixed venous oxygen saturation (SvO(2)). Both sensors we
re mounted on leads that were implanted in the right ventricle.
Methods Twenty-one patients with heart failure (NYHA II-III) were included.
Comparisons were made to right heart catheterizations at implant and at 2,
6 and 12 months thereafter, Patients underwent several haemodynamic provoc
ations during the catheterizations.
Results Overall, among functioning sensors, the IHM-1 values were highly co
rrelated with reference values for all time points during all provocations,
demonstrating high reproducibility and stability (r(2)=0.91, 0.79 and 0.78
for systolic, right ventricular diastolic and SvO(2) respectively). Althou
gh IHM-1 underestimated reference pressure values by 4.5 mmHg and SvO(2) by
1.6%, this difference was consistent across provocation and stable over 12
months of follow-up. Twelve of the 21 oxygen sensors failed to function an
d two pressure sensors had component failures. Preliminary analysis of long
-term data revealed haemodynamic patterns that may be key indicators for th
erapeutic interventions.
Conclusion This multicentre feasibility study demonstrated the accuracy and
stability of sensors implanted in the right ventricle. The IHM-1, using ri
ght ventricular pressures and SvO(2) with improved performance, might be us
eful in the study of pathophysiological mechanisms and treatment interventi
ons in heart failure. (C) 2001 The European Society of Cardiology.